After participating in this educational activity, attendees should be able to:
1.Distinguish relevant updates to STI epidemiology, management, and prevention, including pandemic considerations
2. Highlight OB/GYN pertinent areas of the upcoming 2020 CDC STD Treatment Guidelines that may undergo greatest change
3. Review clinical resources to access expert guidance on STD management at point-of-care
Katherine Hsu, MD, MPH, FAAP
Medical Director, Division of STD Prevention & HIV/AIDS Surveillance
Director, Ratelle STD/HIV Prevention Training Center
Director, Medical Education
Bureau of Infectious Disease and Laboratory Sciences
Massachusetts Department of Public Health
The design and content of Baystate Continuing Interprofessional Education ( CE ) activities support quality improvement in healthcare and provide fair and balanced views of therapeutic options. Faculty or planner conflicts of interest are resolved before the educational activity.
Dr. Katherine Hsu plans to present information on some non-FDA approved dosing requirements for STI syndromes.
None of the members of the planning committee for this educational event have commercial relationships with any entity producing, marketing, re-selling or distributing health care goods and services consumed by or used on patients.
- 1.00 AMA PRA Category 1 Credit™
- 1.00 ANCC Contact Hours
- 1.00 BCIPE Instructional Hours